(Q33686632)

28 July 2017

title

The opioid growth factor-opioid growth factor receptor axis regulates cell proliferation of human hepatocellular cancer (English)

1 reference

Kevin F Staveley-O'Carroll

28 July 2017

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author

7

object named as

Kevin F Staveley-O'Carroll

1 reference

28 July 2017

Diego M Avella

1

1 reference

28 July 2017

Eric T Kimchi

2

1 reference

28 July 2017

Renee N Donahue

3

1 reference

28 July 2017

Hephzibah Rani S Tagaram

4

1 reference

28 July 2017

Patricia J McLaughlin

5

1 reference

28 July 2017

Ian S Zagon

6

1 reference

28 July 2017

publication date

18 November 2009

1 reference

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

28 July 2017

published in

1 reference

28 July 2017

volume

298

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

R459-66

1 reference

Dependence on nuclear localization signals of the opioid growth factor receptor in the regulation of cell proliferation

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

Strategy and mechanism for the prevention of hepatocellular carcinoma: phosphorylated retinoid X receptor alpha is a critical target for hepatocellular carcinoma chemoprevention

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

Molecularly targeted therapy for hepatocellular carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

The OGF-OGFr axis utilizes the p16INK4a and p21WAF1/CIP1 pathways to restrict normal cell proliferation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

Prevention and delay in progression of human squamous cell carcinoma of the head and neck in nude mice by stable overexpression of the opioid growth factor receptor

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

Prevention and delay in progression of human pancreatic cancer by stable overexpression of the opioid growth factor receptor.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

Imiquimod upregulates the opioid growth factor receptor to inhibit cell proliferation independent of immune function

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

Design and endpoints of clinical trials in hepatocellular carcinoma.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

The OGF-OGFr axis utilizes the p21 pathway to restrict progression of human pancreatic cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

The opioid growth factor (OGF)-OGF receptor axis uses the p16 pathway to inhibit head and neck cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

Overexpression of the opioid growth factor receptor potentiates growth inhibition in human pancreatic cancer cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

Overexpression of the opioid growth factor receptor downregulates cell proliferation of human squamous carcinoma cells of the head and neck.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

The inhibitory effect of opioids on HepG2 cells is mediated via interaction with somatostatin receptors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

Global cancer statistics, 2002

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

Nucleocytoplasmic distribution of opioid growth factor and its receptor in tongue epithelium

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

Rising plasma nociceptin level during development of HCC: a case report

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

Increased nociceptin/orphanin FQ plasma levels in hepatocellular carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

21 June 2018

Hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

Opioid growth factor inhibition of a human squamous cell carcinoma of the head and neck in nude mice: dependency on the route of administration.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

The expression and function of the OGF-OGFr axis - a tonically active negative regulator of growth - in COS cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

The toxicity of opiates and their metabolites in HepG2 cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

Opioids and the apoptotic pathway in human cancer cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

Immunoelectron microscopic localization of the opioid growth factor receptor (OGFr) and OGF in the cornea

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

Estimating the world cancer burden: Globocan 2000.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

Regulation of human head and neck squamous cell carcinoma growth in tissue culture by opioid growth factor

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

Human pancreatic cancer cell proliferation in tissue culture is tonically inhibited by opioid growth factor

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

Opioid growth factor tonically inhibits human colon cancer cell proliferation in tissue culture

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

Methods used for the study of opioid receptors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

Opioid receptors and endogenous opioids in diverse human and animal cancers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828179

Human renal cell cancer proliferation in tissue culture is tonically inhibited by opioid growth factor

21 June 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00646.2009

Defects in the opioid growth factor receptor in human squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00646.2009

Production and characterization of polyclonal and monoclonal antibodies to the zeta (zeta) opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00646.2009

The biology of the opioid growth factor receptor (OGFr)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00646.2009

10.1152/AJPREGU.00646.2009

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference

28 July 2017

1 reference